These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29767951)
1. Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX). Yang WJ; Zhou P; Liang L; Cao Y; Qiao J; Li X; Teng Z; Wang L ACS Appl Mater Interfaces; 2018 Jun; 10(22):18560-18573. PubMed ID: 29767951 [TBL] [Abstract][Full Text] [Related]
2. Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy. Zhong Y; Zhang L; Sun S; Zhou Z; Ma Y; Hong H; Yang D J Nanobiotechnology; 2021 Oct; 19(1):333. PubMed ID: 34688292 [TBL] [Abstract][Full Text] [Related]
3. [An injectable hydrogel/staple fiber composite for sustained release of CA4P and doxorubicin for combined chemotherapy of xenografted breast tumor in mice]. Wang T; Yang L; Xie Y; Cheng S; Xiong M; Luo X Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):625-632. PubMed ID: 35673904 [TBL] [Abstract][Full Text] [Related]
5. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma. Zhu J; Xu X; Hu M; Qiu L J Biomed Nanotechnol; 2015 Jun; 11(6):997-1006. PubMed ID: 26353589 [TBL] [Abstract][Full Text] [Related]
6. Injectable and pH-Responsive Silk Nanofiber Hydrogels for Sustained Anticancer Drug Delivery. Wu H; Liu S; Xiao L; Dong X; Lu Q; Kaplan DL ACS Appl Mater Interfaces; 2016 Jul; 8(27):17118-26. PubMed ID: 27315327 [TBL] [Abstract][Full Text] [Related]
7. Injectable, NIR/pH-Responsive Nanocomposite Hydrogel as Long-Acting Implant for Chemophotothermal Synergistic Cancer Therapy. Xu X; Huang Z; Huang Z; Zhang X; He S; Sun X; Shen Y; Yan M; Zhao C ACS Appl Mater Interfaces; 2017 Jun; 9(24):20361-20375. PubMed ID: 28532154 [TBL] [Abstract][Full Text] [Related]
8. Versatile functionalization of surface-tailorable polymer nanohydrogels for drug delivery systems. Yang WJ; Liang L; Wang X; Cao Y; Xu W; Chang D; Gao Y; Wang L Biomater Sci; 2018 Dec; 7(1):247-261. PubMed ID: 30465554 [TBL] [Abstract][Full Text] [Related]
9. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Qu J; Zhao X; Ma PX; Guo B Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effect. Zhu J; Hu M; Qiu L J Pharm Pharmacol; 2017 Jul; 69(7):844-855. PubMed ID: 28425588 [TBL] [Abstract][Full Text] [Related]
11. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
13. Injectable and Self-Healing Thermosensitive Magnetic Hydrogel for Asynchronous Control Release of Doxorubicin and Docetaxel to Treat Triple-Negative Breast Cancer. Xie W; Gao Q; Guo Z; Wang D; Gao F; Wang X; Wei Y; Zhao L ACS Appl Mater Interfaces; 2017 Oct; 9(39):33660-33673. PubMed ID: 28901139 [TBL] [Abstract][Full Text] [Related]
14. Hollow gold nanoshells-incorporated injectable genetically engineered hydrogel for sustained chemo-photothermal therapy of tumor. Jin R; Yang J; Zhao D; Hou X; Li C; Chen W; Zhao Y; Yin Z; Liu B J Nanobiotechnology; 2019 Sep; 17(1):99. PubMed ID: 31530285 [TBL] [Abstract][Full Text] [Related]
15. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845 [TBL] [Abstract][Full Text] [Related]
16. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
17. Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy. Huang P; Song H; Zhang Y; Liu J; Zhang J; Wang W; Liu J; Li C; Kong D ACS Appl Mater Interfaces; 2016 Nov; 8(43):29323-29333. PubMed ID: 27731617 [TBL] [Abstract][Full Text] [Related]
18. Shear-responsive injectable supramolecular hydrogel releasing doxorubicin loaded micelles with pH-sensitivity for local tumor chemotherapy. Liu Z; Xu G; Wang C; Li C; Yao P Int J Pharm; 2017 Sep; 530(1-2):53-62. PubMed ID: 28739501 [TBL] [Abstract][Full Text] [Related]
19. Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin. Singh M; Kundu S; Reddy M A; Sreekanth V; Motiani RK; Sengupta S; Srivastava A; Bajaj A Nanoscale; 2014 Nov; 6(21):12849-55. PubMed ID: 25227567 [TBL] [Abstract][Full Text] [Related]
20. Sequential delivery of bismuth nanoparticles and doxorubicin by injectable macroporous hydrogels for combined anticancer kilovoltage X-ray radio- and chemo-therapy. Deng J; Xun X; Zheng W; Su Y; Zheng L; Wang C; Su M J Mater Chem B; 2018 Dec; 6(47):7966-7973. PubMed ID: 32255041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]